Does EBV early antigen (EA) IgG above the reference range indicate recent infection or reactivation?

Epstein-Barr Virus (EBV) serology is a critical tool for distinguishing between latent carriage and active viral replication. While standard past infection is characterized by the presence of VCA-IgG and EBNA-1 antibodies, the appearance of Early Antigen (EA) IgG signals a transition into the lytic cycle.

Clinical and effectiveness evidence

In clinical practice, EA IgG is recognized as a specific indicator of active EBV replication.

• Active Infection vs. Latency: In acute infectious mononucleosis (IM), EA IgG is detectable in approximately 85% of patients. In contrast, studies of healthy populations show that EA IgG is typically absent, with positivity rates as low as 0% to 3.1%.
• Reactivation Patterns: For individuals with remote past infections, a rise in EA IgG alongside existing VCA-IgG and EBNA-1 antibodies is the hallmark of viral reactivation. This is frequently observed in patients with autoimmune conditions or immunosuppression; for example, EA IgG levels are significantly higher in patients with systemic lupus erythematosus (SLE) compared to healthy controls (p < 0.05).
• Persistence: While highly indicative of active replication, EA IgG may persist at low levels in approximately 20% of healthy individuals for years, though this is considered a deviation from the standard "remote past" profile.

Mechanistic explanations

The interpretation of EA IgG is rooted in the viral life cycle.

• Lytic Cycle Induction: EBV EA-D (diffuse) polypeptides are expressed during the early phase of the lytic cycle, occurring after the immediate-early genes but before viral DNA synthesis.
• Immune Response: The production of IgG antibodies against these early proteins confirms that the immune system is responding to active viral protein synthesis and assembly rather than a dormant, latent infection.

Bottom line

EBV EA IgG above the reference range is a validated marker of recent primary infection or reactivation. While it should be interpreted as part of a full serological panel, its presence distinctly indicates active viral replication, whereas it is typically negative in a stable, remote past infection.